The value of ventilation/perfusion scanning and CT pulmonary angiography in predicting chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a one-year follow-up study.
Acute pulmonary embolism
CT pulmonary angiography
Chronic thromboembolic pulmonary hypertension
Ventilation/perfusion scanning
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
08
03
2022
accepted:
19
04
2022
medline:
21
9
2023
pubmed:
20
9
2023
entrez:
19
9
2023
Statut:
ppublish
Résumé
To investigate the value of ventilation/perfusion (V/Q) scanning and CT pulmonary angiography (PA) in predicting CTEPH development after acute pulmonary embolism (APE). This study was performed in APE patients who had undergone both V/Q and CT PA after 3-month anticoagulation. The residual pulmonary obstructions were assessed based on V/Q and CT PA, and then recorded as pulmonary perfusion detect score (PPDs) and CT pulmonary artery obstruction index (PAOI). The predictive performance of PPDs and CT PAOI for CTEPH were determined and risk factors for predicting CTEPH development were identified. A total of 235 patients with initial diagnosis of APE were included in this study. ROC analysis showed that the AUCs of the PPDs and CT PAOI were 0.957 and 0.895, with corresponding cut-off values of 20.50% and 17.50% for predicting CTEPH development. Neither sensitivity nor specificity differed significantly between PPDs and CT PAOI (Sensitivity: 92.00% vs. 80.00%, P = 0.25; Specificity: 88.10% vs. 89.52%, P = 0.69). The univariable and multivariable logistic regression analysis demonstrated that pulmonary arterial hypertension confirmed by echocardiography at initial APE diagnosis (OR: 6.16, 95%CI: 1.31-29.02, P = 0.02), a PPDs of > 20.50% (OR: 22.95, 95%CI: 2.37-222.19, P = 0.007), and a CT PAOI of > 17.50% (OR: 9.98, 95%CI: 2.06-48.49, P = 0.004) were associated with CTEPH development. Both V/Q and CT PA after 3-month anticoagulation for APE showed great performance in predicting CTEPH development, and V/Q scanning has a tendency to be more sensitive but less specific than CT PA. The residual pulmonary embolism detected by V/Q and CT PA was associated with an increased risk of CTEPH development.
Identifiants
pubmed: 37726464
doi: 10.1007/s10554-022-02629-5
pii: 10.1007/s10554-022-02629-5
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2249-2259Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A et al (2017) Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature. Eur Respir J 49(2):1601792. https://doi.org/10.1183/13993003.01792-2016
doi: 10.1183/13993003.01792-2016
pubmed: 28232411
Papamatheakis DG, Poch DS, Fernandes TM, Kerr KM, Kim NH, Fedullo PF (2020) Chronic thromboembolic pulmonary hypertension: JACC focus seminar. J Am Coll Cardiol 76(18):2155–2169. https://doi.org/10.1016/j.jacc.2020.08.074
doi: 10.1016/j.jacc.2020.08.074
pubmed: 33121723
Kamada H, Ota H, Nakamura M et al (2022) Quantification of vortex flow in pulmonary arteries of patients with chronic thromboembolic pulmonary hypertension. Eur J Radiol 148. https://doi.org/10.1016/j.ejrad.2021.110142
Konstantinides SV, Meyer G, Becattini C et al (2020) ESC Scientific Document Group 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J 41(4):543–603. https://doi.org/10.1093/eurheartj/ehz405
doi: 10.1093/eurheartj/ehz405
pubmed: 31504429
Rivera-Lebron B, McDaniel M, Ahrar K et al (2019) PERT consortium, diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT consortium. Clin Appl Thromb Hemost 25. https://doi.org/10.1177/1076029619853037
Pepke-Zaba J, Delcroix M, Lang I et al (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124(18):1973–1981. https://doi.org/10.1161/CIRCULATIONAHA.110.015008
doi: 10.1161/CIRCULATIONAHA.110.015008
pubmed: 21969018
Albani S, Biondi F, Stolfo D, Lo Giudice F, Sinagra G (2019) Chronic thromboembolic pulmonary hypertension (CTEPH): what do we know about it? A comprehensive review of the literature. J Cardiovasc Med 20(4):159–168. https://doi.org/10.2459/JCM.0000000000000774
doi: 10.2459/JCM.0000000000000774
Bonnefoy PB, Margelidon-Cozzolino V, Catella-Chatron J et al (2019) What’s next after the clot? Residual pulmonary vascular obstruction after pulmonary embolism: from imaging finding to clinical consequences. Thromb Res 184:67–76. https://doi.org/10.1016/j.thromres.2019.09.038
doi: 10.1016/j.thromres.2019.09.038
pubmed: 31710860
Tapson VF, Platt DM, Xia F et al (2016) Monitoring for pulmonary hypertension following pulmonary embolism: The INFORM Study. Am J Med 129(9):978-985.e2. https://doi.org/10.1016/j.amjmed.2016.03.006
doi: 10.1016/j.amjmed.2016.03.006
pubmed: 27046247
Bajc M, Schümichen C, Grüning T et al (2019) EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond. Eur J Nucl Med Mol Imaging 46(12):2429–2451. https://doi.org/10.1007/s00259-019-04450-0
doi: 10.1007/s00259-019-04450-0
pubmed: 31410539
pmcid: 6813289
Wang L, Wang M, Yang T, Wu D, Xiong C, Fang W (2020) A Prospective, comparative study of ventilation-perfusion planar imaging and ventilation-perfusion SPECT for chronic thromboembolic pulmonary hypertension. J Nucl Med 61(12):1832–1838. https://doi.org/10.2967/jnumed.120.243188
doi: 10.2967/jnumed.120.243188
pubmed: 32198309
Meyer G, Collignon MA, Guinet F, Jeffrey AA, Barritault L, Sors H (1990) Comparison of perfusion lung scanning and angiography in the estimation of vascular obstruction in acute pulmonary embolism. Eur J Nucl Med 17(6–8):315–319. https://doi.org/10.1007/BF01268022
doi: 10.1007/BF01268022
pubmed: 2126770
Wittram C, Waltman AC, Shepard JA, Halpern E, Goodman LR (2007) Discordance between CT and angiography in the PIOPED II study. Radiology 244(3):883–889. https://doi.org/10.1148/radiol.2443061693
doi: 10.1148/radiol.2443061693
pubmed: 17664436
Qanadli SD, El Hajjam M, Vieillard-Baron A et al (2001) New CT index to quantify arterial obstruction in pulmonary embolism: comparison with angiographic index and echocardiography. AJR Am J Roentgenol 176(6):1415–1420. https://doi.org/10.2214/ajr.176.6.1761415
doi: 10.2214/ajr.176.6.1761415
pubmed: 11373204
Wilkens H, Konstantinides S, Lang IM et al (2018) Chronic thromboembolic pulmonary hypertension (CTEPH): Updated recommendations from the Cologne Consensus Conference 2018. Int J Cardiol 272S:69–78. https://doi.org/10.1016/j.ijcard.2018.08.079
doi: 10.1016/j.ijcard.2018.08.079
pubmed: 30195840
Sahutoglu E, Tuncay E, Aras G et al (2021) Chronic thromboembolic pulmonary hypertension in patients with persistent chest symptoms after acute pulmonary embolism. Anatol J Cardiol 25(1):24–29. https://doi.org/10.14744/AnatolJCardiol.2020.69057
doi: 10.14744/AnatolJCardiol.2020.69057
pubmed: 33382052
Otero R, Oribe M, Ballaz A et al (2011) Echocardiographic assessment of pulmonary arterial pressure in the follow-up of patients with pulmonary embolism. Thromb Res 127(4):303–308. https://doi.org/10.1016/j.thromres.2010.12.010
doi: 10.1016/j.thromres.2010.12.010
pubmed: 21247617
Korkmaz A, Ozlu T, Ozsu S, Kazaz Z, Bulbul Y (2012) Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost 18(3):281–288. https://doi.org/10.1177/1076029611431956
doi: 10.1177/1076029611431956
pubmed: 22275389
Pengo V, Lensing AW, Prins MH et al (2004) Thromboembolic Pulmonary Hypertension Study Group Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 350(22):2257–2264. https://doi.org/10.1056/NEJMoa032274
doi: 10.1056/NEJMoa032274
pubmed: 15163775
Pesavento R, Filippi L, Palla A et al (2017) SCOPE Investigators Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism. Eur Respir J 49(5):1601980. https://doi.org/10.1183/13993003.01980-2016
doi: 10.1183/13993003.01980-2016
pubmed: 28546279
Yang S, Yang Y, Zhai Z et al (2015) Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism. J Thorac Dis 7(11):1927–1938. https://doi.org/10.3978/j.issn.2072-1439.2015.11.43
doi: 10.3978/j.issn.2072-1439.2015.11.43
pubmed: 26716031
pmcid: 4669266
Marion D, Adam T, Deepa G et al (2021) ERS statement on chronic thromboembolic pulmonary hypertension. Eur Respir J 57(6):2002828. https://doi.org/10.1183/13993003.02828-2020
doi: 10.1183/13993003.02828-2020
Wang M, Wu D, Ma R et al (2020) Comparison of V/Q SPECT and CT angiography for the diagnosis of chronic thromboembolic pulmonary hypertension. Radiology 296(2):420–429. https://doi.org/10.1148/radiol.2020192181
doi: 10.1148/radiol.2020192181
pubmed: 32427559
Yandrapalli S, Tariq S, Kumar J et al (2018) Chronic thromboembolic pulmonary hypertension: epidemiology, diagnosis, and management. Cardiol Rev 26(2):62–72. https://doi.org/10.1097/CRD.0000000000000164
doi: 10.1097/CRD.0000000000000164
pubmed: 28832374
Moser KM, Bloor CM (1993) Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 103(3):685–692. https://doi.org/10.1378/chest.103.3.685
doi: 10.1378/chest.103.3.685
pubmed: 8449052
Mrozek J, Petrova J, Vaclavkova J, Janovsky V, Kraus L, Jansa P (2018) Reperfusion after pulmonary embolism—long-term follow-up, risk factors, clinical impact. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 162(2):121–126. https://doi.org/10.5507/bp.2018.001
doi: 10.5507/bp.2018.001
pubmed: 29375141
Fernandes T, Planquette B, Sanchez O, Morris T (2016) From acute to chronic thromboembolic disease. Ann Am Thorac Soc 13(Suppl 3):S207-214. https://doi.org/10.1513/AnnalsATS.201509-619AS
doi: 10.1513/AnnalsATS.201509-619AS
pubmed: 27571002
den Exter PL, van Es J, Kroft LJ et al (2015) Prometheus Follow-up investigators thromboembolic resolution assessed by CT pulmonary angiography after treatment for acute pulmonary embolism. Thromb Haemost 114(1):26–34. https://doi.org/10.1160/TH14-10-0842
doi: 10.1160/TH14-10-0842
Yu Y, Yang L, Zhang Y et al (2018) Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world. Clin Respir J 12(11):2551–2558. https://doi.org/10.1111/crj.12955
doi: 10.1111/crj.12955
pubmed: 30160381